Aldosterone blockade in post-acute myocardial infarction heart failure.

about

Evaluation of the aldosterone-blocking agent eplerenone in hypertension and heart failure.

P2860

Q37000764-A609C62C-5E0C-4133-85CC-E81E3C1A64BC

P2860

Aldosterone blockade in post-acute myocardial infarction heart failure.

Item

http://www.wikidata.org/entity/Q36634189

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Aldosterone blockade in post-acute myocardial infarction heart failure.

@ast

Aldosterone blockade in post-acute myocardial infarction heart failure.

@en

type

Item

label

Aldosterone blockade in post-acute myocardial infarction heart failure.

@ast

Aldosterone blockade in post-acute myocardial infarction heart failure.

@en

prefLabel

Aldosterone blockade in post-acute myocardial infarction heart failure.

@ast

Aldosterone blockade in post-acute myocardial infarction heart failure.

@en

P1476

Aldosterone blockade in post-acute myocardial infarction heart failure

@en

P2093

Bertram Pitt

http://www.w3.org/2001/XMLSchema#string

John McMurray

http://www.w3.org/2001/XMLSchema#string

Jose Lopez-Sendon

http://www.w3.org/2001/XMLSchema#string

Mihai Gheorghiade

http://www.w3.org/2001/XMLSchema#string

Roberto Ferrari

http://www.w3.org/2001/XMLSchema#string

P2860

Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)

Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2)

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Aldosterone blockade in patients with systolic left ventricular dysfunction.

Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation.

Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure.

Appraisal of the role of angiotensin II and aldosterone in ventricular myocyte apoptosis in adult normotensive rat.

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.

Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction.

P304

434-438

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CLC.4960291004

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mihai Gheorghiade

Bertram Pitt

Dirk J van Veldhuisen

Henry Krum

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6732077

http://www.w3.org/2001/XMLSchema#string

P698

17063946

http://www.w3.org/2001/XMLSchema#string

P932

6653947

http://www.w3.org/2001/XMLSchema#string

Aldosterone blockade in post-acute myocardial infarction heart failure.

about

P2860

P2860

Aldosterone blockade in post-acute myocardial infarction heart failure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932